Dr Reddy's Laboratories Ltd

Integrated Annual Report

Report overview

The report presents Dr. Reddy's FY2026 consolidated revenue of ₹335.9 billion, up 3%. It reports SBTi validation of an 80% absolute Scope 1 and 2 reduction target and a 51.6% Scope 3 intensity reduction target by FY2030, alongside a value-chain net-zero target for FY2045. Environmental highlights include 78% renewable power and group-level AWS certification across five sites.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2025-2026
Period: 1 April 2025 – 31 March 2026
Publication date: 12 May 2026
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Scope 3 emissions
Energy consumption
Renewable energy
Water consumption
Waste
Employees
Women on the board
Workplace fatalities
Net zero target

Materiality

Assessment
Basis
Matrix

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services